Search research articles
Contact Us
Filters
Showing results (241-250 of 575) with videos related to
Page
of 58
Sort By:
Human Pathology
|
April 17, 2009
Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology
Kazutoshi Fujita, Christian P Pavlovich, George J Netto, et al.
Cancer Research
|
June 19, 2001
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling
J Luo, D J Duggan, Y Chen, et al.
The Journal of Urology
|
August 28, 1998
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy
G S Bova, A W Partin, S D Isaacs, et al.
Molecular Cancer Therapeutics
|
March 29, 2011
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)
Brice A P Wilson, Haofan Wang, Benjamin A Nacev, et al.
International Journal of Cancer
|
November 13, 2008
Endoglin (CD105) as a urinary and serum marker of prostate cancer
Kazutoshi Fujita, Charles M Ewing, David Y S Chan, et al.
Cell & Bioscience
|
June 28, 2013
Specific structure and unique function define the hemicentin
Xuehong Xu, Mengmeng Xu, Xin Zhou, et al.
Cancer Research
|
November 13, 2003
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer
Shan Zha, Sacha Ferdinandusse, Simone Denis, et al.
Carcinogenesis
|
October 23, 2004
Prostate carcinogenesis and inflammation: emerging insights
Ganesh S Palapattu, Siobhan Sutcliffe, Patrick J Bastian, et al.
The Prostate
|
January 21, 2006
Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk
Jielin Sun, Fang-Chi Hsu, Aubrey R Turner, et al.
Genomics
|
January 1, 1994
Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-q22
J D McPherson, R A Morton, C M Ewing, et al.
Page
of 58
Search research articles
Search
Showing results (241-250 of 575) with videos related to
Sort By:
Page
of 58
Human Pathology
|
April 17, 2009
Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology
Kazutoshi Fujita, Christian P Pavlovich, George J Netto, et al.
Cancer Research
|
June 19, 2001
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling
J Luo, D J Duggan, Y Chen, et al.
The Journal of Urology
|
August 28, 1998
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy
G S Bova, A W Partin, S D Isaacs, et al.
Molecular Cancer Therapeutics
|
March 29, 2011
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)
Brice A P Wilson, Haofan Wang, Benjamin A Nacev, et al.
International Journal of Cancer
|
November 13, 2008
Endoglin (CD105) as a urinary and serum marker of prostate cancer
Kazutoshi Fujita, Charles M Ewing, David Y S Chan, et al.
Cell & Bioscience
|
June 28, 2013
Specific structure and unique function define the hemicentin
Xuehong Xu, Mengmeng Xu, Xin Zhou, et al.
Cancer Research
|
November 13, 2003
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer
Shan Zha, Sacha Ferdinandusse, Simone Denis, et al.
Carcinogenesis
|
October 23, 2004
Prostate carcinogenesis and inflammation: emerging insights
Ganesh S Palapattu, Siobhan Sutcliffe, Patrick J Bastian, et al.
The Prostate
|
January 21, 2006
Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk
Jielin Sun, Fang-Chi Hsu, Aubrey R Turner, et al.
Genomics
|
January 1, 1994
Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-q22
J D McPherson, R A Morton, C M Ewing, et al.
Page
of 58